Previous 10 | Next 10 |
home / stock / phcuf / phcuf news
Photocure ASA press release (OTC:PHCUF): Q4 GAAP EPS of -NOK 1.05. Revenue of NOK 94.5M (-3.5% Y/Y). EBITDA before restructuring for the fourth quarter was -NOK 5.5M. Cash balance at the end of the fourth quarter of 2021 was NOK 322.9 million (NOK 334.9 million). Net cash used in the fou...
Photocure to Present at Two Upcoming Investor Conferences in June PR Newswire OSLO, Norway , 27 May 2021 /PRNewswire/ -- Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that President and Chief Executive Officer, Daniel Schne...
Photocure ASA: Results for the first quarter of 2021 PR Newswire OSLO, Norway , May 19, 2021 /PRNewswire/ -- Photocure ASA (OSE:PHO), the Bladder Cancer Company, today reported Hexvix ® /Cysview ® revenues of NOK 81.6 million in the fi...
Photocure announces Hexvix regulatory filing accepted for review in Chile with Fast Track designation PR Newswire OSLO, Norway , May 18, 2021 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that notification was given to its part...
Photocure ASA: Results for the fourth quarter of 2020 PR Newswire OSLO, Norway , March 3, 2021 /PRNewswire/ -- Photocure ASA (OSE: PHO) reports Hexvix ® /Cysview ® revenues of NOK 97.7 million in the fourth quarter of 2020 (Q4 2019: ...
New abstracts on the use of Blue Light Cystoscopy with Cysview presented at SUO OSLO, Norway , Dec. 7, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announced new data and analyses presented at the 21 st Annual Meeting of the Society of Urologic Oncology (SUO)...
New data analysis on Blue Light Cystoscopy efficiency presented at the virtual BLADDR 2020 congress PR Newswire OSLO, Norway, Oct. 16, 2020 OSLO, Norway , Oct. 16, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces a highlight from the BLADDR ...
Photocure announces new Cevira patent in Europe PR Newswire OSLO, Norway, Oct. 5, 2020 OSLO, Norway , Oct. 5, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces that the European Patent Office (EPO) has granted patent EP 2983780 covering the comme...
Photocure launches European Hexvix operations PR Newswire OSLO, Norway, Oct. 1, 2020 OSLO, Norway , Oct. 1, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces the commencement of the sales, marketing and distribution of Hexvix ® in th...
Photocure ASA ( OTC:PHCUF ) : Q2 EBITDA loss of NOK8.9M More news on: Photocure ASA, Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Photocure Asa Company Name:
PHCUF Stock Symbol:
OTCMKTS Market:
Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial PR Newswire OSLO, Norway , Aug. 9, 2022 /PRNewswire/ -- On August 9, 2022 , Asieris Pharmaceuticals, a global biopharmaceutical company specializ...
Photocure ASA: Results for the first quarter of 2022 PR Newswire OSLO, Norway , May 11, 2022 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 81.4 million in the first quarter of 2022 (Q1 ...
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in China PR Newswire OSLO, Norway , March 11, 2022 /PRNewswire/ -- Photocure ASA ( PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharm...